Notably, in glioma, the MALT1 protease enhances the immunosuppressive phenotype of TAMs through NF-κB pathway activation, while MALT1 inhibitors reverse this effect and restore antitumor immune responses (202). This evidence concerns the gene MALT1 and glioma.